Corcept Therapeutics, Inc. (NASDAQ:CORT)

CAPS Rating: 2 out of 5

A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.

Recs

0
Player Avatar godsmacks1 (57.13) Submitted: 12/19/2007 1:43:29 PM : Underperform Start Price: $2.84 CORT Score: -47.07

sub prime

Featured Broker Partners


Advertisement